Comparative Assessment of Esophagitis in Cases With and Without Esophageal Motility Disorders: A Prospective Study
Comparative Assessment of Reflux Esophagitis in Cases With and Without Esophageal Motility Disorders
1 other identifier
interventional
200
1 country
1
Brief Summary
Achalasia is a neuro-degenerative disorder marked by changes in the peristalsis of the esophagus and the lack of relaxation in the lower esophageal sphincter (LES), thought to be due to damage to the myenteric plexus with an unknown cause.1 Per-oral endoscopic myotomy (POEM) is an established endoscopic treatment modality for achalasia. Leading gastrointestinal (GI) societies endorse POEM as one of the primary treatment option for achalasia.This study aims to characterize and compare the morphological characteristics of reflux related erosions after the POEM procedures versus those in cases without esophageal motility disorders. Data collection
- 1.Demographic characteristics: Age, gender, type of achalasia
- 2.Manometry findings (pre and post POEM): integrated relaxation pressure, lower esophageal sphincter pressure
- 3.Comorbidities
- 4.Medications
- 5.Eckardt score: before procedure and 3-months after Procedure
- 6.POEM procedure details: length of esophageal and gastric myotomy, adverse events, length of hospital stay
- 7.Evaluation at 3-months Symptom: standardized questionnaire (GERDQ) Endoscopy: grade of esophagitis Erosions vs ulcers Dimension of erosions Anatomical location (according to clock)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 11, 2024
CompletedFirst Submitted
Initial submission to the registry
February 8, 2025
CompletedFirst Posted
Study publicly available on registry
February 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2025
CompletedFebruary 19, 2025
February 1, 2025
10 months
February 8, 2025
February 13, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
comparison of reflux esophagitis in cases who undergo POEM procedure versus those without esophageal motility disorders
Reflux esophagitis can be calculated as grade B category (red colour scar found in esophagus mucosa) during endoscopy procedure
3 months
Assessment of the , esophageal acid exposure
esophageal acid exposure is a value indicates higher reflux can be calculated in ph impedence report
6 months
Study Arms (2)
Assesment of reflux esophagitis in cases with esophageal motility
ACTIVE COMPARATORReflux esophagitis can be found in Endoscopy report.
Assesment of reflux esophagitis in cases without esophageal motility
PLACEBO COMPARATORReflux esophagitis can be found in cases in normal gastroesophageal reflux disease condition patients
Interventions
POEM is the procedure to reduce the symptoms of dysphagia, regurgitation.
Endoscopy procedure is required to rule out type of reflux disease
Eligibility Criteria
You may qualify if:
- Age≥18y,
- confirmed diagnosis of Achalasia,
- No contraindication to POEM,
- erosive esophagitis on endoscopy
You may not qualify if:
- Non-esophageal esophageal motility disorders,
- Treatment other than POEM,
- current PPI use before assessment for GERD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asian Institute of Gastroenterology Hospital
Hyderabad, Telangana, 500082, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zaheer Nabi Dr Mohammed, MBBS MD
AIG Hospitals
- PRINCIPAL INVESTIGATOR
Chinmay Dr Hegde, MBBS MD
AIG Hospitals
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
February 8, 2025
First Posted
February 19, 2025
Study Start
May 11, 2024
Primary Completion
February 28, 2025
Study Completion
May 10, 2025
Last Updated
February 19, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share